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The cytoplasmic juxtamembrane region of the p75
neurotrophin receptor (p75NTR) has been found to be
necessary and sufficient to initiate neural cell death.
The region was named “Chopper” to distinguish it from
CD95-like death domains. A 29-amino acid peptide cor-
responding to the Chopper region induced caspase- and
calpain-mediated death in a variety of neural and non-
neural cell types and was not inhibited by signaling
through Trk (unlike killing by full-length p75NTR). Chop-
per triggered cell death only when bound to the plasma
membrane by a lipid anchor, whereas non-anchored
Chopper acted in a dominant-negative manner, blocking
p75NTR-mediated death both in vitro and in vivo. Re-
moval of the ectodomain of p75NTR increased the po-
tency of Chopper activity, suggesting that it regulates
the association of Chopper with downstream signaling
proteins.
The p75 neurotrophin receptor (p75NTR), a member of the
tumor necrosis factor receptor (TNFR)1 family, was the first
receptor to be described for nerve growth factor (NGF) (1) and
can bind to each of the neurotrophins (brain-derived neurotro-
phic factor, neurotrophin-3, and neurotrophin-4/5) with similar
equilibrium constants (2, 3). Subsequently, the Trk (tyrosine
kinase receptor) family, members of which have varying spec-
ificity for each neurotrophin, was described (4). Ligand binding
to a Trk receptor activates a phosphorylation signal cascade,
resulting in cell survival and process outgrowth (4, 5); and
p75NTR has been shown to facilitate Trk signal transduction by
the formation of high affinity neurotrophin receptor complexes
(6).
p75NTR can mediate cellular effects independently of associ-
ation with Trk, such as the activation of nuclear factor kB
(7–10), c-Jun (10, 11), and ceramide (12, 13). Although provid-
ing a definite function for p75NTR signaling remains controver-
sial, there is substantial evidence to support the hypothesis
that p75NTR can initiate a neural cell death pathway. Overex-
pression of p75NTR increases cell death in Trk-expressing cells
(14–17), whereas lowered expression of p75NTR decreases neu-
ronal death both in vitro and in vivo (11, 18–20). Furthermore,
the apparent activation of p75NTR by neurotrophins in cells
lacking the appropriate Trk receptor results in cell death in a
number of experimental paradigms. The addition of NGF to
developing chick optic nuclei or NGF (attached to glass beads)
applied to developing chick retinas leads to increased cell death
(21, 22), whereas the addition of blocking antibodies to either
NGF or p75NTR decreases naturally occurring chick retinal cell
death (23). Cultured sympathetic neurons and proprioceptive
neurons also display increased cell death after the addition of
brain-derived neurotrophic factor and NGF, respectively; and it
was again possible to block this cell death by application of
p75NTR antibodies (11, 24). Oligodendrocytes and Schwann
cells also show p75NTR-dependent cell death after treatment
with NGF, provided TrkA is not coexpressed (8, 25).
p75NTR has sequence similarity to other TNFR family mem-
bers both in the cysteine-rich ectodomain and in the cytoplas-
mic sequence known as a “death domain” (26). Despite the
presence of a death domain in p75NTR, there is accumulating
evidence that this region does not mediate the ability of p75NTR
to promote cell death. Unlike the TNFR death domain, the
death domain of p75NTR does not interact with other death
domain-containing proteins (16), does not spontaneously mul-
timerize in solution (27), and does not function in the same
manner (28). Moreover, we have recently shown that without
the juxtamembrane sequence, p75NTR is unable to induce neu-
ronal cell death, whereas deletion of the death domain se-
quence has no effect on the ability of p75NTR to kill (16).
Little is known about the downstream components of the
p75NTR death signaling pathway, although it is known that
caspases are ultimately activated (see Ref. 29). Bcl-2 does not
inhibit cell death induced by p75NTR (16, 25) and can in fact
promote p75NTR-mediated cell death in some circumstances
(16). In contrast, Bcl-xL can inhibit p75
NTR-mediated cell death
(16). Recently, the six TRAF proteins, which are capable of
activating nuclear factor kB, have been shown to associate with
various regions of the p75NTR cytoplasmic domain (30, 31). Two
novel zinc finger proteins, neurotrophin receptor interacting
factor and SC-1, have also been found to interact with the
cytoplasmic domains of p75NTR and appear to mediate cell
death (32, 33). However, the precise role of these proteins in
p75NTR death signaling is unclear at this stage. Further char-
acterization of the responsible death-inducing portion of
p75NTR may ultimately help to determine the role of these and
other p75NTR-interacting proteins in p75NTR and Trk signaling.
To determine how the p75NTR death signal is transduced, the
components within the p75NTR cytoplasmic region required for
death signal initiation were sought. The domain that is both
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necessary and sufficient for initiating p75NTR cell death was
found to be the cytoplasmic juxtamembrane 29-amino acid
sequence we have named “Chopper.” It was found that mem-
brane attachment was critical for cell death initiated by Chop-
per and that the ectodomain regulated Chopper activity. Chop-
per was shown to kill via a calpain- and caspase-mediated
death pathway that is independent of Trk signaling and that is
present in a variety of cell types.
MATERIALS AND METHODS
Cell Culture—Dorsal root ganglia were dissected from postnatal day
0 C57Bl/6 mice and cultured as described previously (16). PC12 cells
were grown in Dulbecco’s modified Eagle’s medium containing 10%
fetal bovine serum and 5% horse serum (Commonwealth Serum Labo-
ratories), differentiated with NGF (50 ng/ml; Peprotech) and serum
withdrawal, and cultured for a further 5 days prior to microinjection.
Wild-type Schwann cells and the 293T and M1 cell lines were main-
tained in Dulbecco’s modified Eagle’s medium and 10% fetal bovine
serum.
Microinjection and Transfection—Sensory dorsal root ganglial neu-
rons, rat PC12 cells, and human 293T fibroblast cells were microin-
jected with DNA at individual concentrations ranging from 100 to 20
mg/ml as described previously (16). Unless otherwise stated, DNA con-
centrations were 100 mg/ml. Where two plasmids were injected to-
gether, the total DNA concentration did not exceed 220 mg/ml, and
toxicity was not observed at this concentration. Live cells were identi-
fied by their phase-bright morphology and, in some cases, propidium
iodide exclusion.
Transient transfections of PC12, 293T, and wild-type Schwann cells
were performed using Effectine (QIAGEN Inc.), and the numbers of live
GFP-expressing cells were determined by FACS or cell counts. Cell
survival of sptc35-transfected cells was compared with cells expressing
GFP vectors. M1 cells were treated with 2 mM Palm29pen, and cell
survival was compared with PalmCpen-treated cells. GFP protein ex-
pression levels were determined 24 h after transfection by FACS.
Schwann cells, stably transfected with Bcl-2 (25), were transfected with
GFP or c35 by a CaCl2 method and glycerol shock (34) and then sorted
by FACS for GFP expression after 24 h. Apoptosis was induced in
Schwann cells by the addition of 10 ng/ml NGF in basal medium as
described previously (25).
DNA Constructs—All p75NTR plasmids contain modified versions of
rat p75 cDNA. Expression vectors were either pPUC9 with a 550-base
pair phosphoglycerate kinase (pgk) promoter (18) or pIRES-EGFP
(CLONTECH). All pPUC9 constructs retain p75 39-untranslated se-
quences from the BglII site (position 1760). p75NTRnc, p75NTRtr, and
p75NTRD35 have been previously described (16). sptc (signal peptide-
transmembrane-cytoplasmic) constructs were made by fusing the AflIII
site (position 208) with the SacII site (position 849) of rat p75NTR,
creating a Trp codon and bringing together Thr32 and Thr247. sptc35 is
truncated with an I308A substitution. c35 constructs were made by
polymerase chain reaction, amplifying the juxtamembrane 35-amino
acid p75NTR fragment, which was then cloned into the pIRES-EGFP
vector (EcoRI and BamHI sites), followed by introduction of double-
stranded oligonucleotide “fragments” into the NotI and EcoRI sites,
which include a Kozak sequence and an initiation methionine. The
sptc35 Cys-to-Ala mutation was introduced by polymerase chain reac-
tion.2 All constructs were DNA-sequenced; and where possible, protein
expression was determined by immunohistochemistry.
Peptides—The 35-amino acid peptide corresponding to rat p75NTR
residues 274–308 was purchased from Chiron (Melbourne, Australia).
This sample was ;40% pure, with the major impurity being a des-Pro
34-residue contaminant. All other peptides were synthesized in-house
using Fmoc amino acids activated with O-benzotriazol-1-yl-N,N,N9,N9-
tetramethyluronium hexafluorophosphate. Peptides were synthesized
on a Rink amide 4 methylbenzhydrylamine (MBHA) resin support so
that all peptides contained a C-terminal amide group. Fluorescein-
labeled peptides were generated by coupling 5- (and 6-)-carboxyfluores-
cein succinimidyl ester (Molecular Probes, Inc.) to the amino-terminal
end of a resin-bound peptide prior to its cleavage and deprotection. A
palmitoylated analog of p75NTR (residues 274–302) was prepared by
coupling Fmoc-Lys-(e-palmitoyl) to the resin-bound 29-residue peptide,
removing the Fmoc group, and then fluorescein labeling as described
previously. The control peptide, KELPRQPpYFKQNCSQ, was similarly
palmitoylated. Peptides were purified to homogeneity by reverse-phase
HPLC, and their covalent structures were confirmed by matrix-assisted
laser desorption ionization mass spectrometry.
The penetratin peptide, CRQIKIWFPNRRMKWKK (35), contained a
unique cysteine residue at the amino terminus to facilitate conjugation,
via a disulfide bond, to p75NTR peptides that also contained a unique
cysteine residue. The penetratin cysteine residue was activated with
2,29-dipyridyl disulfide to generate the S-2-pyridylsulfenyl derivative,
and this product was purified by HPLC. Formation of penetratin-
p75NTR peptide conjugates was achieved by mixing 2 eq of derivatized
penetratin with 1 eq of p75NTR peptide in 6 M guanidine hydrochloride
and 100 mM Tris (pH 7.4), incubating for several hours at room tem-
perature, and then purifying by HPLC.
The caspase inhibitor peptides t-butoxycarbonyl-D-fmk and benzyl-
oxycarbonyl-DEVD-fmk (Calbiochem) were reconstituted in Me2SO and
diluted in 0.1 M Tris buffer (pH 8.0). The calpain inhibitors N-acetyl-
Leu-Leu-norleucinal and PD150606 (Calbiochem) were reconstituted
fresh in Me2SO. Inhibitors were applied to neurons (3-h pretreatment)
for a total of 5 h, including the 2-h incubation with 1 mM Chopper
peptides, with a final 1% concentration of Me2SO in all conditions. Cell
survival was determined by phase-bright morphology and propidium
iodide exclusion.
Retinal Ganglial Death Assay—Cell death of retinal ganglia from
developing chicken embryos was quantified using an enzyme immuno-
assay for histones (Roche Molecular Biochemicals) as described previ-
ously (22, 36). Using a 30-gauge needle and a Hamilton syringe, 1 ml of
solution (100 mM diluted in phosphate-buffered saline) was injected into
the eye vitreous of E4.5–5 fertilized chicken embryos. The eggs were
allowed to develop for a further 24 h, and the retinal ganglial cell layer
was dissected from E5.5–6 embryos into phosphate-buffered saline
containing Complete protease inhibitors (Roche Molecular Biochemi-
cals) and homogenized by trituration through a 25-gauge needle. Cells
were lysed and analyzed according to assay instructions by enzyme-
linked immunosorbent assay measuring relative cell death by absorb-
ance at l405.
RESULTS
p75NTR Mediates Cell Death through the Cytoplasmic Jux-
tamembrane Domain Called Chopper—To fully characterize
the critical region of the p75NTR cytoplasmic domain that is
both sufficient and necessary to mediate cell death, a series of
expression constructs were made in which one or more protein
domains of rat p75NTR were deleted (Fig. 1A). The ability of the
resulting truncated p75NTR proteins to mediate cell death was
determined by microinjection of these constructs into the nuclei
of freshly isolated sensory neurons cultured in the presence of
leukemia inhibitory factor (LIF) and measuring cell survival
over the next 24 h.
Constructs retaining the cytoplasmic juxtamembrane 35-
amino acid domain along with the ectodomain (p75, p75NTRtr)
were able to mediate neuronal death, whereas those lacking
this domain (p75NTRnc, p75NTRD35) were not (Fig. 1B), a result
that is in agreement with earlier findings (16). This indicated
that the domain required for p75NTR death signaling is the
juxtamembrane domain and not the region with homology to
the CD95 and TNFR death domains.
To determine whether the ectodomain of p75NTR is necessary
to mediate the death signaling pathway, a construct lacking
the ectodomain (but retaining the signal peptide sequence,
transmembrane domain, and entire 152 amino acid cytoplas-
mic domain, sptc152) (Fig. 1A) was tested for its ability to kill.
It was found that removal of the ectodomain significantly in-
creased the killing ability and more than doubled the amount of
cell death induced by full-length p75NTR (Fig. 1B). The con-
struct was then further truncated, removing the region with
homology to the CD95 death domain as well as the ectodomain
(sptc35) (Fig. 1A), and this was found to induce significantly
more neuronal death compared with sptc152, killing .90% of
the cells within 16 h of microinjection (Fig. 1B). In contrast to
full-length p75NTR (16), these constructs retained the ability to
induce cell death in the context of NGF-Trk survival signaling
(data not shown).
Suprisingly, expression of the juxtamembrane 35-amino acid2 Oligonucleotide sequences are available on request.
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p75NTR fragment with no transmembrane sequence (c35) (Fig.
1A) did not promote cell death in the presence of LIF; cells
expressing c35 (confirmed by FLAG epitope staining (data not
shown)) survived as well as cells expressing p75NTR with no
cytoplasmic tail (p75NTRnc) (Fig. 1B).
To rule out the possibility that the degree of killing was due
to increased expression of the truncated constructs, each
p75NTR protein was coexpressed with GFP from an internal
ribosome-binding site such that the expression of GFP was
proportional to the expression of p75NTR (see “Materials and
Methods”). 293T cells were transiently transfected with the
various constructs, and the level of GFP expression was deter-
mined by FACS. No significant difference in expression was
observed between any of the various constructs expressing
truncated p75NTR forms and full-length p75NTR-expressing vec-
tor (Fig. 1C).
The results indicated that the membrane-linked 35-amino
acid domain was required not only for p75NTR-mediated death
signaling, but was, by itself, sufficient to induce cell death that
was of greater potency than when it was linked to other do-
mains. This killing domain of p75NTR has been named Chopper
to distinguish it from the CD95 homologous death domain
region.
Free Chopper Inhibits p75NTR-mediated Killing—As c35 was
unable to induce cell death, we examined whether it might act
to inhibit p75NTR-mediated cell death by a dominant-negative
mechanism. When c35 was coexpressed with sptc35 in neurons,
it was found to inhibit cell death in a dose-dependent fashion
(Fig. 2A).
To ascertain whether the Chopper sequence also mediates
cell death in other paradigms of p75NTR-mediated death, we
tested the effect of c35 expression in a Schwann cell system
where it has been shown that NGF induces cell death through
endogenous p75NTR (25). Transfected Schwann cells expressing
c35 or GFP were plated in the presence or absence of NGF, and
their survival was monitored over a 24-h period. c35 expression
was found to significantly abrogate Schwann cell death, block-
ing .90% of NGF-induced cell death compared with the GFP
control (Fig. 2B). This strongly suggests that NGF-induced
Schwann cell death is mediated through a Chopper-dependent
pathway.
Previously, we had shown that Bcl-2 enhanced neuronal
death mediated by p75NTR overexpression (16), so the effect of
c35 on this neuronal death pathway was also examined. When
c35 was coexpressed with p75NTR and Bcl-2, it again totally
abrogated the effects of p75NTR-mediated killing (Fig. 2C),
again suggesting that this pathway is dependent on Chopper
activity.
The ability of c35 to inhibit neuronal cell death due to stress
stimuli, namely NGF withdrawal, was also tested. No increase
in survival of neurons treated with c35 was observed after 48 h
(Fig. 2D). This result was consistent with our previous obser-
vation that the death pathway used by cells dying from stress
stimuli is distinct from the p75NTR-mediated death pathway
(16).
Free Chopper Peptides Prevent Death Signaling in Vitro and
in Vivo—To further examine the requirements for death induc-
tion by the Chopper domain and to confirm the inhibitory
action of c35, cell-permeable p75NTR-derived peptides were
synthesized. Due to ease of synthesis, a 29-residue (lacking the
6 carboxyl-terminal amino acids), in addition to the 35-residue
peptide of the Chopper sequence, was synthesized and modified
as shown in Fig. 3A (see “Materials and Methods”). To facilitate
intracellular delivery of synthetic p75NTR-derived peptides, a
17-residue cell-permeable penetratin peptide (35) was conju-
gated to p75NTR peptides via a disulfide bond (see “Materials
and Methods”). This linkage is stable in the extracellular, but is
rapidly reduced once the complex is internalized, liberating the
p75NTR peptide from penetratin (37).
Fluorescein-labeled p75NTR-derived c29 peptide conjugated
to penetratin (c29pen) was rapidly taken up by neurons and
was observed throughout the cell, as judged by fluorescence
FIG. 1. Chopper, a small juxtamembrane domain of p75NTR, is
required and sufficient to mediate neuronal death. A, shown is a
schematic of p75NTR proteins expressed by various expression vectors.
Numbers indicate the amino acids at which the truncated proteins vary
from the full-length protein (see “Materials and Methods”). B, shown is
the survival of sensory neurons in the presence of LIF 16 h after
microinjection with various expression constructs at 100 mg/ml. The
graph is a compilation from five experiments, standardized to control
vectors 6 S.E. *, p , 0.05; ***, p , 0.001 C, p75NTR-IRES-EGFP
expression constructs were transiently transfected into 293T cells; and
after 24 h, 50,000 PI negative cells were monitored for GFP expression
by FACS. Expression levels did not significantly differ between con-
structs of differing sizes.
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microscopy including confocal imaging (Figs. 3B and 4, A, C,
and E). At a peptide concentration of 10 or 15 mM, all neurons
were found to be fluorescent after 30 min, whereas at 3 mM,
,20% of the cells were fluorescent at this time point (Fig. 3B).
Longer treatment of cells with 3 mM peptide (2 h) did, however,
result in all cells taking up the peptide (data not shown). In
contrast, no appreciable uptake of non-conjugated peptides
(c29) could be detected (Fig. 4, B, D, and F), even after a 24-h
incubation with 15 mM peptide (data not shown). Treatment for
up to 2 h with a 15 mM concentration of the penetratin-linked
free Chopper peptides had no significant effect on neuronal
survival after 16 h in either NGF (76.2 6 7.9%) or LIF (88.3 6
3%) compared with untreated cells (86.6 6 1.8 and 85.4 6 5.3%,
respectively); however, toxic effects were observed when neu-
rons were treated with penetratin alone or penetratin-linked
peptides at concentrations .20 mM and applied for .2 h (data
not shown).
To test the ability of these p75NTR peptides to prevent cell
death, neurons were injected with sptc35 or control GFP ex-
pression plasmids and then treated for 30 min with 15 mM
synthetic c35-penetratin conjugate (c35pen) or penetratin
alone (pen). Neurons injected with sptc35 and then treated
with cell-permeable c35pen peptide had a significant survival
advantage over penetratin-alone treated cells (Fig. 5A). The
29-residue peptide (c29pen) lacking the 6 carboxyl-terminal
residues of c35 was found to confer equivalent protection
against sptc35-mediated cell death (Fig. 5A).
The free Chopper peptides were then utilized to determine
whether the Chopper domain functions during development of
the nervous system. Developmental cell death of chick retinal
ganglial neurons occurs during early embryogenesis (E3–7)
and has been shown to be mediated through NGF and p75NTR
(22, 23). To test if Chopper could inhibit retinal ganglial cell
death, various peptides (pen, c29pen, and c29) were injected
FIG. 2. Free Chopper protects neurons from cell death. A, sen-
sory neurons in LIF were co-injected with different ratios of the two
expression vectors sptc35 and c35, keeping sptc35 at 20 mg/ml. Survival
of neurons injected with 200 mg/ml c35 alone is standardized to 100%.
A 1:10 plasmid ratio of sptc35 to c35 resulted in complete protection
against sptc35-induced killing after 15 h (mean 6 S.E., n 5 3). B, rat
Schwann cells treated with NGF showed significant cell death over
24 h, which was inhibited by expression of the c35 construct, with cell
survival not significantly different from GFP-expressing cells cultured
in Dulbecco’s modified Eagle’s medium (DME) alone (mean 6 S.E., n 5
6). C, c35, p75NTR, and Bcl-2 plasmids were co-injected into sensory
neurons, and survival was assessed after 16 h. Coexpression of c35
inhibited constitutive killing mediated by p75NTR and Bcl-2 overexpres-
sion, with cell survival not significantly different from coexpression of
Bcl-2 and c35 (mean 6 S.E., n 5 2). D, sensory neurons were subject to
NGF withdrawal 16 h after microinjection (t 5 0), and survival was
monitored for a further 20 h. There was no significant difference in the
amount of cell death after NGF withdrawal (gray bars) between neu-
rons injected with GFP or c35 constructs, although significant cell death
occurred under both conditions compared with neurons maintained in
NGF (black bars) (mean 6 S.E., n 5 2). *, p , 0.05.
FIG. 3. Construction and uptake of cell-permeable Chopper
peptides. A, peptides were synthesized and modified in a number of
ways as described under “Materials and Methods.” Fluorescein (F) was
conjugated to the c29 Chopper peptides; cell-permeable penetratin pep-
tides (pen) were linked by a disulfide bond to the peptides. c29 and
control peptide derived from gp130 (PalmC) were also modified by the
addition of a lysine-palmitoyl residue to the amino-terminal end prior to
fluorescein conjugation and penetratin linkage. B, uptake of the c29pen
peptide was dose-dependent. Cells in LIF were treated with 10 mM l or
3 mM f peptide for 30 min and then washed to remove excess peptide.
Cell counts were performed prior to treatment, immediately after wash-
ing, and then during the following 22 h, assessing the percentage of
strongly fluorescent live cells.
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into the vitreous of E4.5 chick eyes in ovo. At E5.5, the retinal
ganglial layer was dissected from the embryos and analyzed for
apoptotic cell death. c29pen was found to significantly reduce
the degree of cell death by 40% (Fig. 5B), indicating that the
Chopper domain is involved in initiating downstream signaling
of the p75NTR cell death pathway during the period of naturally
occurring cell death.
Lipid-modified Chopper Peptides Cause Cell Death—Our ob-
servations that transmembrane Chopper (sptc35) was a potent
inducer of death and that free Chopper specifically inhibited
this activity suggested that both proteins bound to the same
accessory protein(s), but that membrane localization was re-
quired to activate the death pathway. To further explore
whether the killing activity of p75NTR requires the transmem-
brane sequence or whether membrane attachment per se is
sufficient, lipid-modified (palmitoylated) forms of pro-survival
Chopper peptides were generated to localize them to the
plasma membrane (38, 39). The synthetic 29-mer Chopper pep-
tide was modified by conjugation of lysine-e-palmitoyl and flu-
orescein moieties to the amino terminus (Palm29pen) (Fig. 3A);
and its cellular localization and ability to induce neuronal
death, when delivered as a penetratin conjugate, were
examined.
Interestingly, the addition of the lipid group reduced the
concentration of penetratin-linked peptide required for cellular
uptake: 97 6 4.2% of the cells were visibly fluorescent after
incubation in 2 mM Palm29pen for 30 min compared with ,20%
with c29pen treatment (see Fig. 3B). In contrast to cells treated
with non-palmitoylated peptides (Fig. 4, A, C, and E), cells
often associated with membranes and was especially obvious in mem-
branes that had begun to form large blebs at the surface of neurons (G,
arrows). Other neurons showed accumulation of fluorescence in vacu-
oles that appeared to be budding off at the cell surface (H). By 2 h, many
of the neurons that had taken up the palmitoylated c29pen peptide (J)
were dead, as shown by their crenated and shrunken appearance (I) and
the uptake of propidium iodide into their nuclei (K). A, B, and I,
phase-contrast micrographs (bar 5 50 mm); C, D, and J, conventional
fluorescence micrographs (bar 5 50 mm); E–H, single confocal fluores-
cence micrographs (bar 5 5 mm).
FIG. 4. Uptake and effect of penetratin-coupled Chopper pep-
tides. Sensory neurons cultured in the presence of NGF showed signif-
icant uptake of 20 mM penetratin-conjugated, fluorescein-labeled 29-
mer Chopper peptides after 2 h (c29pen) (A and C), whereas neurons
treated with 20 mM penetratin-free c29 peptide showed no evidence of
internal fluorescence after 2 h (B and D). Fluorescent confocal images
confirmed the accumulation of c29 coupled to penetratin (c29pen) in the
cytoplasm of neurons, as seen in this neuronal cluster (E), and the
complete absence of fluorescence in c29-treated neurons (F) after a 1-h
treatment at 15 mM. Confocal examination of neurons treated with 2 mM
palmitoylated c29pen for 1 h showed intense fluorescence, which was
FIG. 5. Free Chopper peptides inhibit neuronal death. A, 2 h
after microinjection of sptc35 constructs into neurons in the presence of
LIF, neurons were treated for 30 min with 10 mM either penetratin
alone, c35pen, or c29pen peptides. The number of live neurons was
counted after removal of peptide from the medium (t 5 0) and again
after 16 h. Both the c35pen and c29pen peptides gave significant pro-
tection from sptc35 killing in the presence of penetratin. GFP-express-
ing, c29pen peptide-treated neurons are standardized to 100% (mean 6
S.E., n 5 3). B, the eyes of E4.5 chicks were incubated with 100 mM
peptide for 24 h and then assayed for apoptosis (see “Materials and
Methods”). Degree of cell death is standardized to uninjected eyes.
c29pen-treated retina showed a 40% reduction in cell death compared
with pen- or c29-treated retina. Values indicate means 6 S.E. The
number of animals is indicated within the bars. *, p , 0.05; **, p ,
0.025; ***, p , 0.01.
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treated with Palm29pen showed visible changes in morphology
within 1 h of treatment: the neurons had large surface vacuoles
or “blebbing” (Fig. 4, G and H) reminiscent of classical apopto-
sis (40, 41). The localization of palmitoylated Chopper was
throughout the cell, but was particularly noticeable in the
plasma membrane of the vacuoles (Fig. 4G); and fluorescein
was highly concentrated in membrane “blebs” attached to the
cell body and neurites (Fig. 4H). In addition, dead cells had
morphological changes consistent with apoptosis (41), includ-
ing crenated appearance and condensed, propidium iodide-pos-
itive chromatin (Fig. 4, I, J, and K). Indeed, neurons treated
with the palmitoylated Chopper peptide underwent very rapid
cell death within the 2-h treatment period, in contrast to cells
treated with non-palmitoylated peptides: an unrelated peptide,
PalmCpen (derived from gp130), that was also palmitoylated
and conjugated to penetratin (Fig. 6A), or Palm29, which was
not conjugated to penetratin (data not shown), none of which
showed evidence of morphological changes. This suggested that
Chopper initiated a death signal shortly after peptide internal-
ization, but only when it interacted with the plasma mem-
brane. Moreover, it strongly suggested that the transmem-
brane sequence of p75NTR was not important in determining
the ability of the Chopper domain to mediate cell death.
Since p75NTR has been shown to be normally palmitoylated
at cysteine 279, which is within the Chopper domain (42), we
examined whether this residue may be critical to killing. Be-
cause Palm29pen was palmitoylated through a modified lysine
residue and because the peptide might be further palmitoy-
lated at cysteine 279 (used for penetratin conjugation) after
reduction of the disulfide bond (Fig. 3A), cysteine 279 was
substituted in the sptc35 expression construct with alanine.
Unlike sptc35, expression of sptc35 C 3 A in neurons did not
induce cell death (Fig. 6B), indicating that Cys279 is necessary
for the cell killing activity of Chopper.
Chopper Death Signaling Is Independent of Trk and Is Me-
diated through Calpains and Caspases—The ability of palmi-
toylated Chopper peptides to kill within 2 h of application
suggested that the downstream components of the death path-
way were already present in the neurons and did not require
up-regulated expression for death induction. To determine
whether these components are found specifically in neurons,
the ability of membrane-associated Chopper (expression con-
structs and peptides) to kill a range of cell types was deter-
mined. Membrane-associated Chopper was found to kill
Schwann cells, 293T fibroblast cells, and M1 lymphocytes,
which do not express Trk (43–45), as well as sensory neurons
and differentiated and undifferentiated neuroblastoma PC12
cells (see “Materials and Methods”; data not shown). This im-
plied that the death machinery utilized by the Chopper se-
quence was present in a variety of cell types and was independ-
ent of the presence of Trk. Although sptc35 was a potent
inducer of death in 293T cells (29 6 1%), full-length p75NTR and
p75NTRtr (85 6 2.6%) surprisingly did not induce any 293T cell
death, even in the presence of 50 ng/ml NGF, suggesting that a
component of p75NTR activation, present in dorsal root ganglial
neurons, is lacking in 293T cells.
Recently, the PEST domain of IkB was shown to bind to the
calmodulin-like domain of the large subunit of the m-calpain
protease, and such interaction, in the presence of calcium, was
sufficient to activate calpain (46). The presence of a PEST
domain in Chopper (47) suggests that calpain binding and
activation may possibly occur in p75NTR-mediated cell death.
Therefore, the ability of Chopper to kill in the presence of
calpain inhibitors was determined. Neurons were pretreated
for 3 h with cell-permeable inhibitors of calpains and subse-
quently for 2 h with Palm29pen. Cell survival in the presence
of NGF was monitored for a further 17 h. Pretreatment of
neurons with the calpain inhibitors N-acetyl-Leu-Leu-norleuci-
nal (data not shown) and PD150606 (Fig. 7A) prevented
Palm29pen-mediated cell death in a dose-dependent manner.
This indicates that calpain participates in the Chopper-medi-
ated death pathway.
Caspases have previously been shown to be a necessary
component of the p75NTR death pathway (16, 25, 48). To ascer-
tain whether caspases as well as calpains are a component of
the Chopper death pathway, cell-permeable peptide inhibitors
of caspases were employed (49). Neurons were treated with
t-butoxycarbonyl-D-fmk or benzyloxycarbonyl-DEVD-fmk (50)
and subsequently treated with Palm29pen as described above.
Pretreatment of neurons with caspase inhibitors prevented
Palm29pen-mediated cell death in a dose-dependent manner
(Fig. 7B). These results indicate that Chopper requires activa-
tion of caspases that cleave the DEVD sequence, namely
caspase-2, -3, and -7, for execution of cell death.
FIG. 6. Lipid modification allows Chopper to signal cell death.
A, neurons in NGF were treated with 2 mM peptides over 2 h; and their
survival was assessed before treatment (t 5 0), after washing (t 5 2),
and after a further 3 h. Palm29pen (l ) caused rapid cell death (p ,
0.001) compared with the control peptides c29pen (f) and pen () or
with the palmitoylation control PalmCpen (E) (mean 6 S.E., n 5 2). B,
sptc35 constructs were microinjected into sensory neurons in the pres-
ence of LIF, and cell survival was assessed after 16 h. Unlike sptc35,
expression of sptc35 C279A (Cys-to-Ala mutation in Chopper) had no
effect on cell viability, with survival not significantly different from
c35-expressing neurons (standardized to 100%) (mean 6 S.E., n 5 2).
***, p , 0.001.
FIG. 7. p75NTR death pathway components include calpain and
caspases. Sensory neuronal cell death induced by 2-h treatment with
1 mM Palm29pen was prevented, in a dose-dependent fashion, by a 3-h
pretreatment with the calpain inhibitor PD150606 (A) or the caspase
inhibitors t-butoxycarbonyl-D-fmk (BocD-fmk) and benzyloxycarbonyl-
DEVD-fmk (zDEVD-fmk) (B). The number of live cells, grown in NGF,
was counted prior to peptide treatment (t 5 0), and then cell death was
determined 17 h after removal of peptides. The graphs have been
standardized to show c29pen cell death as 0% (mean 6 S.E., n 5 3).
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DISCUSSION
A New p75NTR Death Domain:Chopper—The study has iden-
tified a juxtamembrane 29-amino acid region of p75NTR as
being both required for and sufficient to induce rapid cell death.
This region, along with the transmembrane region, is the most
highly conserved sequence of p75NTR: 95% identity between
rat, human, and chicken (47). It is not, however, conserved
between other members of the TNFR/CD95 family of death
receptors and shows little sequence homology to other known
protein domains. The region does, however, contain a PEST
sequence (residues 287–300), a region rich in proline, aspar-
tate, glutamate, serine, and threonine residues flanked by clus-
ters rich in basic amino acids, which has traditionally been
associated with accelerated protein degradation through facil-
itating interactions with other molecules (see below for further
discussion) (51). This new juxtamembrane death-promoting
region of p75NTR has been named Chopper to distinguish it
from the putative death domain previously ascribed to p75NTR
on the basis of its homology to the death-activating domains,
especially type II found in the TNFR/CD95 receptor family (26).
Our finding confirms work demonstrating that p75NTR does not
contain a domain that functions in the same manner as the Fas
receptor death domain (16, 28). The inhibition of p75NTR-me-
diated developmental cell death in the chick retina by free
Chopper peptides was to a similar extent as that previously
demonstrated with anti-NGF or anti-p75NTR antibodies (23)
and further supports the idea that the Chopper domain is
involved in initiating downstream death signaling. There re-
mains the possibility, however, that motifs within the death
domain may contribute to death signaling in particular circum-
stances (52, 53).
Downstream Signaling through Chopper—Chopper was
found to initiate cell death only if attached to the plasma
membrane through its transmembrane region or if palmitoy-
lated. In addition to targeting Chopper to the membrane,
palmitoylation of p75NTR may play a more direct role in acti-
vation since mutation of cysteine 279 to alanine, through which
p75NTR is normally palmitoylated (42), results in loss of killing
function, despite Chopper being localized to the membrane via
the transmembrane domain. Palmitoylation is a reversible
post-translational modification, targeting proteins to subre-
gions of the plasma membrane known as lipid rafts (54, 55). For
instance, palmitoylation is required for Ras to localize to lipid
rafts, where it interacts with other membrane-localized signal-
ing proteins to initiate signal transduction pathways (56). Sim-
ilarly, lipid modification is required for the receptor clustering
function of the Rapsyn protein (57). By increasing the local
concentration of Chopper and accessory protein complexes,
palmitoylation may, like multimerization of Fas and TNFR (58,
59), lead to initiation of death signaling. Palmitoylation has
also been shown to promote high affinity interactions (39) that
may favor the association of the Chopper domain with binding
partners.
The ability of non-membrane-bound Chopper to inhibit in a
variety of p75NTR-mediated neural death models including de-
velopmental cell death in vivo implies a dominant-negative
mechanism whereby both the membrane-bound form and the
free form interact with the same accessory protein(s). Possible
unidentified interacting partners include proteins that could be
localized to the same lipid microdomains as palmitoylated
p75NTR (39, 60, 61). Free Chopper peptides may prevent cell
death by sequestering such proteins in the cytoplasm and thus
away from membrane-associated Chopper.
Candidates for the role of Chopper-interacting molecules are
members of the TRAF family, which have been shown to me-
diate both cell survival and death signaling in non-neural cells
(62, 63). The TRAF proteins are also implicated in NGF signal-
ing through p75NTR (7, 30, 64, 65). Co-immunoprecipitation
studies have indicated that all six TRAF proteins are associ-
ated with, but may not directly bind to, p75NTR (16, 30, 31) and
that the association is dependent on neurotrophin binding in
some cases (30, 31). Both TRAF4 and TRAF6 have been shown
to associate with the juxtamembrane region, whereas TRAF2
bound to the carboxyl-terminal region. Closer examination us-
ing deletion mutants showed that residues 300–315 of the
juxtamembrane region of p75NTR were required for the inter-
action with TRAF6 to occur (30). Since only 3 amino residues of
this domain overlap with the Chopper domain, TRAF6 is un-
likely to be involved in downstream signaling.
Two zinc finger proteins, neurotrophin receptor interacting
factor (32) and SC-1 (33), have recently been shown to directly
interact with the juxtamembrane domain of p75NTR, and both
have been shown to translocate to the nucleus after NGF bind-
ing to p75NTR (32, 33). Although little is known about the gene
targets of these transcription factors, mice with a targeted
deletion in neurotrophin receptor interacting factor have been
shown to have reduced levels of neuronal death in the devel-
oping retina, suggesting that it plays a role in mediating neu-
ronal death (32) and thus may be downstream of Chopper.
Evidence herein suggested that calpain participates in the
p75NTR death pathway possibly by interacting directly or indi-
rectly with the PEST domain within Chopper. Calpains are a
family of calcium-activated cysteinyl/thiol transferases that are
highly expressed in brain and that play a role in mediating
neuronal apoptosis and necrosis in several chronic neurodegen-
erative diseases, in neural injury, and after ischemia (66).
Calpain, in some cases, has been shown to be more important
than caspases in mediating in vitro models of neuronal death
(66, 67). Although their substrate recognition sequence is dif-
ferent, activated calpains and caspases cleave a number of
common proteins important in apoptotic pathways and can also
cleave each other (66, 67). Thus, it is possible to inhibit calpain-
initiated death signaling with traditional blockers of caspases
such as DEVD, which inhibits caspase-2, -3, and -7 (50, 67),
which we have shown to abrogate the ability of Chopper to kill
(this study and Refs. 16, 25, and 48). Therefore, both calpain
and caspases may be p75NTR-mediated cell death effectors
within the same signaling pathway.
It has recently been shown that p75NTR can regulate cellular
calcium levels, causing an influx of calcium into the cell after
NGF stimulation (68), suggesting that p75NTR may interact
with an ion channel or channel regulator. Furthermore, many
studies show that membrane localization of calpain is neces-
sary for its activation (66), which would explain the require-
ment for membrane attachment for Chopper killing action.
These data are in agreement with our model whereby activa-
tion of p75NTR/Chopper leads to calcium influx, activation of
calpain, and rapid cell death. In addition, calpain-mediated cell
death is not prevented by overexpression of Bcl-2 (67); and
thus, calpain-mediated cell death is consistent with our obser-
vation that Bcl-2 does not inhibit p75NTR-mediated death and
can, in some cases, promote this death (16, 25).
Activation of Chopper—One of the surprising findings was
that Chopper death signaling was substantially inhibited by
the presence of the ectodomain of p75NTR and that, in 293T
cells, there was no observable killing unless the ectodomain
was removed. The ability of NGF to override the death signal in
Trk-expressing cells only when p75NTR retained the ectodo-
main highlighted this and suggested that the ectodomain reg-
ulates Chopper activity by controlling receptor clustering or
perhaps by regulating calcium influx. This raised the question
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of whether removal of the p75NTR ectodomain could be the
cause of physiological activation.
A wide variety of cell-surface proteins (69–71), including
p75NTR (72–75), are released from the plasma membrane by
extracellular cleavage. Metalloproteases, which cleave at a spe-
cific distance from the membrane rather than at sequence-
specific sites, have been shown to be responsible in most cases
(76, 77). p75NTR cleavage is indeed inhibited by metallopro-
tease inhibitors (75), and cleavage also correlates developmen-
tally and temporally with p75NTR acting as a death inducer, e.g.
after sciatic nerve lesion (72, 75, 78, 79). Therefore, we propose
that truncation of p75NTR by proteolytic cleavage within the
ectodomain might be a physiological mechanism for activating
the cell killing ability of p75NTR. Cleavage of the ectodomain of
p75NTR would leave a truncated protein in the membrane
equivalent to the protein produced by the sptc152 construct,
which we have shown to be far more effective at inducing cell
death than full-length p75NTR. Activation of p75NTR death sig-
naling by removal of the ectodomain may explain the perceived
paradoxical circumstances where p75NTR induces death be-
cause a variety of environmental and developmental condi-
tions, other than Trk expression or ligand activation, might
regulate p75NTR cleavage (75, 80).
Conclusion—A truncated protein containing the juxtamem-
brane 29-amino acid p75NTR sequence was shown to be capable
of inducing cell death when linked to the plasma membrane
and was active in a number of cell death paradigms. Evidence
was provided that the death pathway, which did not require
Trk signaling, was likely to be activated by binding of accessory
proteins (present in a variety of cell types) to the juxtamem-
brane domain, resulting in caspase and calpain activation. It is
proposed that physiological activation of the p75NTR death
pathway might be due to ectodomain cleavage of p75NTR, re-
leasing a soluble ectodomain and yielding a death-inducing,
transmembrane-linked form of p75NTR.
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